Redx Pharma plc Notice of Interim Results (1235E)
May 04 2017 - 1:01AM
UK Regulatory
TIDMREDX
RNS Number : 1235E
Redx Pharma plc
04 May 2017
4 May 2017
AIM: REDX
REDX PHARMA PLC
("Redx" or "the Company")
Notice of Interim Results
Redx Pharma, the research and development company focused on
cancer, immunology and infection, announces that its interim
results for the six months ended 31(st) March 2017 will be
announced on Wednesday 17(th) May 2017.
Dr. Neil Murray, Chief Executive Officer, and Andrew Booth,
Interim Finance Director, will host a presentation and conference
call for analysts and investors at 12:30pm BST / 7:30am EDT on the
day of results at the offices of Consilium Strategic
Communications, 41 Lothbury, London, EC2R 7HG. The presentation for
the call will be made available on the Company website
(www.redxpharma.com) in advance of the call.
For further information, please contact:
Redx Pharma Plc
Neil Murray, Chief Executive Officer T: +44 1625
469 900
Karl Hård, Head of Investor Relations T: +44 7491
& 651 406
Corporate Communications
Cantor Fitzgerald Europe (Nomad & Broker) T: +44 20
7894 7000
Phil Davies/ Michael Reynolds
WG Partners LLP (Joint Broker) T: +44 20
3705 9330
Claes Spång/ Chris Lee/ David
Wilson
T: +44 20
Consilium Strategic Communications 3709 5700
Amber Fennell/ Matthew Neal/ Melissa
Gardiner
About Redx Pharma Plc
Company website: www.redxpharma.com
Redx is focused on the discovery and development of proprietary,
small molecule therapeutics to address areas of high, unmet medical
need, principally in cancer, immunology and infection providing a
pipeline of assets to larger and emerging companies. By improving
the characteristics of existing drug classes to create highly
differentiated, novel, best-in-class drugs, Redx has already
established a broad portfolio of proprietary drug programs.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORAJMBTMBBMTIR
(END) Dow Jones Newswires
May 04, 2017 02:01 ET (06:01 GMT)
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Apr 2024 to May 2024
Redx Pharma (LSE:REDX)
Historical Stock Chart
From May 2023 to May 2024